Related Experiment Videos
Phase II evaluation of spirogermanium in malignant melanoma: a Southwest Oncology Group Study
J W Goodwin1, K Kopecky, M Slavik
1University of Kansas Medical Center, Kansas City.
Cancer Treatment Reports
|October 1, 1987
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Carbon sequestration potential of high-altitude afforestation in the Eastern Central Alps.
Journal of environmental management·2026
Perioperative systemic therapy as a part of comprehensive multimodal treatment in esophageal and gastric cancer - new treatment guidelines.
Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2024
Adjuvant accelerated partial-breast irradiation of early-stage breast cancer using stereotactic approach - methodology, technical challenges and early results of prospective randomized trial.
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2022
Prognosis of HPV-Positive and -Negative Oropharyngeal Cancers Depends on the Treatment Modality.
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2019
Stereotactic Body Radiotherapy - Current Indications.
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2019
Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.
Cancer treatment reports·1987
IV melphalan in children.
Cancer treatment reports·1987
Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.
Cancer treatment reports·1987
Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.
Cancer treatment reports·1987
Doxorubicin distribution in human breast cancer.
Cancer treatment reports·1987
Phase I study of echinomycin.
Cancer treatment reports·1987
The impact of oral refined sugar consumption on male reproductive parameters: The role of cessation.
JBRA assisted reproduction·2026
Targeting Distinct Cell Cycle Nodes Overcomes RAS Inhibitor Resistance.
Cancer research·2026
Targeting RAB27A Enhances Pembrolizumab Sensitivity and Alleviates Immune Escape via Inactivation of the PI3K/Akt/mTOR Pathway in Triple-Negative Breast Cancer.
Clinical and experimental pharmacology & physiology·2026